Remote monitoring with BoraCare for adults with COPD and frequent flare-ups
Tests remote monitoring with a device in adults with COPD who often have flare-ups.
Plain-language title generated from the registry record
Registry title: Management of COPD Patients With BoraCare® Remote Monitoring Solution Including BVS3 Early Detection Score for COPD Exacerbations
Key facts
- Where
- Brest, Le Coudray, Lille, Marseille, Montpellier, Paris, Toulouse, Vannes, and Verdun, FranceSee the 10 sites
Where in France
- CHU de BrestBrest, FranceTaking people
- Centre Hospitalier de ChartresLe Coudray, FranceNot yet recruiting
- Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL)Lille, FranceNot yet recruiting
- Hopital Europeen MarseilleMarseille, FranceNot yet recruiting
- Clinique du MillenaireMontpellier, FranceNot yet recruiting
- Hôpital Cochin AP-HPParis, FranceTaking people
- Hôpital de la Pitié Salpêtrière - AP-HPParis, FranceNot yet recruiting
- Centre Hospitalier Universitaire de ToulouseToulouse, FranceNot yet recruiting
- Centre Hospitalier Bretagne AtlantiqueVannes, FranceTaking people
- Centre Hospitalier VerdunVerdun, FranceNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Biosency
- Trial code
- NCT06523140
- Record updated
- 22 August 2025
- Original description
The goal of this clinical trial is to demonstrate the superiority of remote monitoring with the Bora Care solution in patients with COPD and frequent exacerbations (experimental group) compared to conventional follow-up alone (control group) on the total number of hospital days per patient for respiratory deterioration over 12 months of follow-up.Read full original descriptionShow less
Management of Chronic Obstructive Pulmonary Disease (COPD) Patients With BoraCare® Remote Monitoring Solution Including BVS3 Early Detection Score for COPD Exacerbations
The goal of this clinical trial is to demonstrate the superiority of remote monitoring with the Bora Care solution in patients with COPD and frequent exacerbations (experimental group) compared to conventional follow-up alone (control group) on the total number of hospital days per patient for respiratory deterioration over 12 months of follow-up.
The main question it aims to answer is: Does remote monitoring of COPD patients reduce the average annual length of hospitalization for exacerbations of COPD patients?
All participants will benefit a conventional clinical follow-up.
Participants in experimental group will also benefit from the Bora care remote monitoring system.
Inclusion: Patient over 18 years of age with COPD defined according to the recommendations of the SPLF, whose level of respiratory function in a stable state is known (measured less than 12 months), recruited in pulmonology; Patient who has been hospitalized for COPD exacerbation in the previous 12 months; Informed patient who has signed consent,; Patient enrolled in a social security scheme (Art L1121-11 of the CSP).
Exclusion: Presence of a comorbidity considered unstable or very severe by the investigator; Patient with psychological frailties,; Patient already included in another interventional trial,; Patient who does not speak French and is unable to use the Bora Band tool and without access to a caregiver,; Patient protected under guardianship or unable to give free and informed consent; Pregnant or nursing woman.